Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORIA
2020-001102-29Phase 2Active
- Sponsor
- Department of Internal Medicine, Vejle Hospital
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of venetoclax and dexamethasone in multiple myeloma (MM), sponsored by Department of Internal Medicine, Vejle Hospital. Primary endpoint: Overall response rate. Started Apr 2020; status: active.
02
Drugs
venetoclaxdexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2020-001102-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001102-29.